Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 6.55 USD 1.24% Market Closed
Market Cap: 242.5m USD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Growth Rates:
1 Year
+21%
3 Years
-8%
5 Years
-78%
7 Years
-70%
10 Years
-75%
0
Operating Income
+0%
Growth Rates:
1 Year
+66%
3 Years
-
5 Years
-6 193%
7 Years
-
10 Years
-
0
Net Income
+0%
Growth Rates:
1 Year
+77%
3 Years
+71%
5 Years
-53%
7 Years
-
10 Years
-

Earnings Waterfall
Lifecore Biomedical Inc

Revenue
130.9m USD
Cost of Revenue
-85.2m USD
Gross Profit
45.6m USD
Operating Expenses
-51.9m USD
Operating Income
-6.3m USD
Other Expenses
-10.1m USD
Net Income
-16.4m USD

Income Statement
Lifecore Biomedical Inc

Rotate your device to view
Income Statement
Currency: USD
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Nov-2014 Mar-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023 Feb-2024 May-2024 Aug-2024 Nov-2024
Revenue
Revenue
514
N/A
526
+2%
539
+3%
541
+0%
549
+1%
540
-2%
477
-12%
474
-1%
469
-1%
476
+1%
470
-1%
453
-4%
440
-3%
448
+2%
524
+17%
507
-3%
509
+0%
520
+2%
558
+7%
571
+2%
589
+3%
587
0%
160
-73%
157
-2%
(39)
N/A
(148)
-275%
172
N/A
78
-55%
142
+84%
135
-5%
186
+38%
140
-25%
135
-3%
125
-7%
103
-18%
84
-18%
108
+28%
116
+8%
128
+11%
128
+0%
131
+2%
Gross Profit
Cost of Revenue
(447)
(463)
(474)
(472)
(478)
(474)
(410)
(404)
(398)
(394)
(391)
(376)
(367)
(379)
(446)
(433)
(433)
(442)
(477)
(491)
(510)
(509)
(121)
(117)
69
172
(121)
(33)
(95)
(89)
(135)
(101)
(97)
(95)
(75)
(60)
(81)
(83)
(86)
(84)
(85)
Gross Profit
66
N/A
63
-5%
65
+4%
69
+6%
71
+2%
67
-6%
67
0%
70
+5%
72
+2%
82
+15%
79
-4%
77
-3%
73
-5%
69
-5%
78
+13%
74
-5%
76
+3%
78
+2%
81
+4%
81
0%
79
-2%
78
-2%
39
-49%
40
+2%
30
-26%
24
-19%
51
+108%
45
-12%
48
+7%
46
-3%
50
+9%
39
-23%
38
-3%
31
-18%
28
-9%
24
-13%
27
+11%
33
+22%
42
+27%
45
+6%
46
+3%
Operating Income
Operating Expenses
(44)
(45)
(47)
(50)
(53)
(53)
(53)
(89)
(56)
(61)
(62)
(66)
(65)
(62)
(65)
(63)
(65)
(67)
(70)
(78)
(79)
(83)
(48)
(52)
(34)
(23)
(45)
(36)
(39)
(45)
(54)
(56)
(62)
(59)
(48)
(46)
(46)
(45)
(49)
(51)
(52)
Selling, General & Administrative
(37)
(38)
(40)
(43)
(46)
(47)
(46)
(48)
(49)
(53)
(53)
(53)
(51)
(49)
(52)
(50)
(53)
(55)
(59)
(64)
(68)
(71)
(41)
(42)
(25)
(15)
(38)
(29)
(31)
(37)
(46)
(48)
(53)
(50)
(39)
(38)
(37)
(36)
(40)
(42)
(43)
Research & Development
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(8)
(8)
(10)
(10)
(12)
(13)
(13)
(13)
(12)
(12)
(12)
(11)
(12)
(12)
(8)
(7)
(6)
(5)
(7)
(7)
(7)
(8)
(8)
(8)
(8)
(8)
(9)
(9)
(9)
(9)
(9)
(9)
(8)
Other Operating Expenses
0
0
0
0
0
0
0
(34)
0
0
0
(3)
(2)
0
0
0
0
0
0
(3)
0
0
0
(3)
(3)
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
22
N/A
18
-22%
19
+6%
19
+2%
18
-6%
13
-25%
13
+1%
(19)
N/A
15
N/A
21
+39%
17
-20%
11
-38%
8
-25%
7
-10%
14
+92%
11
-20%
12
+6%
11
-3%
11
-4%
3
-75%
(0)
N/A
(5)
-4 700%
(9)
-85%
(12)
-30%
(4)
+66%
2
N/A
5
+184%
9
+57%
9
+5%
1
-87%
(4)
N/A
(17)
-389%
(24)
-40%
(28)
-15%
(20)
+29%
(22)
-10%
(19)
+14%
(12)
+37%
(7)
+39%
(6)
+16%
(6)
-4%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
(1)
(2)
(3)
(5)
(7)
(7)
(5)
(6)
(5)
(6)
(10)
(14)
(17)
(18)
(17)
(14)
(16)
(17)
(18)
(18)
(18)
(16)
(18)
(20)
(21)
Non-Reccuring Items
0
0
0
0
0
(34)
(34)
0
(35)
(3)
(4)
0
0
0
0
0
0
0
(5)
0
(3)
(17)
(17)
(22)
(16)
(6)
(7)
0
(6)
(8)
(55)
(53)
(52)
(49)
(26)
(25)
(26)
(24)
(2)
(6)
(6)
Total Other Income
4
5
3
4
3
1
1
0
0
1
1
2
3
2
3
3
2
2
2
1
0
0
(0)
(0)
(0)
(0)
0
0
0
6
7
12
11
5
(1)
(1)
19
40
36
37
18
Pre-Tax Income
26
N/A
22
-15%
22
-2%
22
+4%
20
-9%
(19)
N/A
(20)
-2%
(19)
+3%
(20)
-5%
19
N/A
14
-24%
13
-11%
11
-12%
10
-14%
16
+71%
14
-18%
13
-2%
12
-12%
4
-69%
(2)
N/A
(10)
-547%
(28)
-193%
(31)
-8%
(40)
-30%
(25)
+37%
(10)
+61%
(12)
-20%
(6)
+52%
(14)
-145%
(19)
-39%
(70)
-272%
(73)
-5%
(80)
-9%
(89)
-11%
(64)
+28%
(65)
-2%
(43)
+34%
(13)
+71%
10
N/A
6
-39%
(15)
N/A
Net Income
Tax Provision
(9)
(8)
(8)
(8)
(7)
7
8
8
8
(6)
(4)
(4)
(3)
0
(5)
(1)
(2)
(3)
(2)
(1)
1
7
9
12
7
2
2
(1)
7
7
6
5
1
1
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Income from Continuing Operations
17
14
14
14
13
(12)
(12)
(12)
(12)
13
10
9
8
10
11
12
12
8
2
(2)
(9)
(22)
(22)
(28)
(18)
(8)
(10)
(6)
(7)
(12)
(64)
(68)
(79)
(88)
(64)
(66)
(43)
(13)
9
6
(15)
Income to Minority Interest
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
17
N/A
14
-16%
14
-3%
14
+5%
13
-9%
(12)
N/A
(12)
+4%
(11)
+3%
(12)
-5%
13
N/A
11
-17%
9
-11%
9
-9%
21
+147%
25
+17%
23
-8%
22
-5%
7
-69%
0
-94%
(5)
N/A
(11)
-133%
(23)
-118%
(38)
-64%
(44)
-16%
(51)
-15%
(45)
+12%
(33)
+27%
(31)
+5%
(57)
-81%
(64)
-13%
(115)
-79%
(117)
-2%
(91)
+22%
(118)
-30%
(100)
+16%
(99)
+1%
(72)
+27%
(16)
+77%
12
N/A
7
-46%
(16)
N/A
EPS (Diluted)
0.62
N/A
0.52
-16%
0.5
-4%
0.52
+4%
0.47
-10%
-0.45
N/A
-0.42
+7%
-0.41
+2%
-0.43
-5%
0.45
N/A
0.38
-16%
0.33
-13%
0.29
-12%
0.75
+159%
0.88
+17%
0.81
-8%
0.78
-4%
0.23
-71%
0.01
-96%
-0.15
N/A
-0.36
-140%
-0.79
-119%
-1.3
-65%
-1.51
-16%
-1.73
-15%
-1.53
+12%
-1.11
+27%
-1.06
+5%
-1.91
-80%
-2.17
-14%
-3.88
-79%
-3.95
-2%
-2.96
+25%
-3.89
-31%
-3.32
+15%
-3.25
+2%
-1.98
+39%
-0.45
+77%
0.32
N/A
0.21
-34%
-0.47
N/A

See Also

Summary
LFCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
LFCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LFCR stock valuation using valuation multiples.
Wall Street Estimates
LFCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LFCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 239,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.